Header Logo

Connection

CHAD CREIGHTON to Proteomics

Back to Details
This is a "connection" page, showing publications CHAD CREIGHTON has written about Proteomics.
CHAD CREIGHTON
Connection Strength
3.103
Proteomics
  1. Using cancer proteomics data to identify gene candidates for therapeutic targeting. Oncotarget. 2023 05 04; 14:399-412.
    View in: PubMed
    Score: 0.601
  2. Clinical proteomics towards multiomics in cancer. Mass Spectrom Rev. 2024 Nov-Dec; 43(6):1255-1269.
    View in: PubMed
    Score: 0.585
  3. Mass-spectrometry-based proteomic correlates of grade and stage reveal pathways and kinases associated with aggressive human cancers. Oncogene. 2021 03; 40(11):2081-2095.
    View in: PubMed
    Score: 0.517
  4. Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers. Nat Commun. 2019 12 12; 10(1):5679.
    View in: PubMed
    Score: 0.475
  5. An Overview of Analytical Approaches to Cancer Proteogenomics. Methods Mol Biol. 2025; 2921:93-118.
    View in: PubMed
    Score: 0.169
  6. Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways. Nat Commun. 2022 05 13; 13(1):2669.
    View in: PubMed
    Score: 0.140
  7. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022 03; 25:18-27.
    View in: PubMed
    Score: 0.138
  8. Proteomic signatures of clear cell renal cell carcinoma. Nat Rev Nephrol. 2020 03; 16(3):133-134.
    View in: PubMed
    Score: 0.121
  9. Pan-urologic cancer genomic subtypes that transcend tissue of origin. Nat Commun. 2017 08 04; 8(1):199.
    View in: PubMed
    Score: 0.101
  10. Reverse phase protein arrays in signaling pathways: a data integration perspective. Drug Des Devel Ther. 2015; 9:3519-27.
    View in: PubMed
    Score: 0.087
  11. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 04; 490(7418):61-70.
    View in: PubMed
    Score: 0.072
  12. A functional annotation of subproteomes in human plasma. Proteomics. 2005 Aug; 5(13):3506-19.
    View in: PubMed
    Score: 0.044
  13. Loss of TRIM62 expression is an independent adverse prognostic factor in acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015 Feb; 15(2):115-127.e15.
    View in: PubMed
    Score: 0.021
  14. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res. 2011 Dec 15; 71(24):7670-82.
    View in: PubMed
    Score: 0.017
  15. Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma. PLoS One. 2011 Mar 23; 6(3):e17177.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.